At what age is the vaccine to prevent cervical cancer suitable?

Vaccines to prevent cervical cancer are suitable for ages 9-45, and the age ranges for different vaccine types vary slightly.

Cervical cancer vaccines mainly include bivalent, quadrivalent and nine-valent HPV vaccines. The bivalent HPV vaccine is suitable for women aged 9-45 and can prevent HPV16 and 18 virus infections. The quadrivalent HPV vaccine is suitable for women aged 20-45. In addition to preventing HPV types 16 and 18, it can also prevent genital warts caused by HPV types 6 and 11. The nine-valent HPV vaccine is suitable for women aged 16-26, covering HPV types 6, 11, 16, 18, 31, 33, 45, 52 and 58, with a wider range of prevention. The World Health Organization recommends that girls aged 9-14 who have not had sexual intercourse be the first targets for vaccination, as the immune response generated by vaccination is stronger at this time. Women over the age of 26 need to undergo an HPV test before vaccination. If they are not infected with the virus subtype covered by the vaccine, vaccination can still obtain protective effects. Women over 45 years old may have been exposed to multiple HPV subtypes, so the effectiveness of vaccination is relatively reduced.

Regular cervical cancer screening is still required after vaccination. Combined with a healthy lifestyle such as a balanced diet, regular exercise, and avoiding smoking, the risk of cervical cancer can be further reduced. Specific vaccination plans should be consulted with professional medical institutions and formulated based on individual circumstances.